Xiangwei Wang
Zhanjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Association of basal metabolic rate with mortality among cancer survivors: a cohort study emphasizing heterogeneity by gender and age.
Journal: Annals of medicine
Published: August 05, 2026
Alternol-Induced Oxidative Modification of SQSTM1/p62 Is Associated with Nrf2 Signaling and Autophagy-Related Responses in Prostate Cancer Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: April 27, 2026
GLUL drives metabolic reprogramming and confers docetaxel resistance in prostate cancer.
Journal: Biochemical pharmacology
Published: March 06, 2026
Upregulation of SFTPC gene expression is associated with disease progression and worse survival outcomes in human skin melanomas.
Journal: Melanoma research
Published: July 01, 2025
Decoding metabolic reprogramming heterogeneity across bladder cancer stages using single-cell and spatial multi-omics approaches.
Journal: Computer methods and programs in biomedicine
Published: June 28, 2025
Expression profiles and clinical significance of cystatin family genes in transitional cell carcinoma of the urinary bladder.
Journal: Bladder (San Francisco, Calif.)
Published: November 09, 2024
Aberrant expression of multiple γ-glutamyltransferases is associated with tumor progression and patient outcome in prostate cancers.
Journal: Frontiers in oncology
Published: October 28, 2024
Association between serum 25-hydroxyvitamin D and prostate cancer in middle-aged and elderly Americans: a national population-based analysis of NHANES 2001-2018.
Journal: BMC cancer
Published: August 11, 2024
Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo.
Journal: Frontiers in pharmacology
Published: March 30, 2024
The Applications of CRISPR/Cas9 System for Urinary System Tumor.
Journal: Current topics in medicinal chemistry
Published: December 05, 2022
Last Updated: 09/26/2026